purpose preliminary informations beneficial use amifostine avoiding effects patients head neck tumors underwent radiotherapy patients method amifostine given daily intravenous application NUMBER mg NUMBER NUMBER minutes prior radiotherapy NUMBER patients results compared collective patients similar results according score mucositis manifest NUMBER patients grade NUMBER patients grade ii amifostine group vs NUMBER patients grade ii NUMBER patients grade iii NUMBER patient grade iv control group xerostomia seen NUMBER patients grade NUMBER patients grade ii administration amifostine drug NUMBER patients suffered xerostomia grade NUMBER patients grade ii NUMBER patients grade iii respectively administering amifostine feasible non problematic small rate toxic effects like nausea NUMBER emesis NUMBER documented conclusions amifostine effective radioprotector decreasing acute late effects patients head neck tumors